Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure

Aydin Ece1, Yildiz Atamer, Fuat Gürkan

  • 1Department of Pediatrics, Faculty of Medicine, Dicle University, Diyarbakir, Turkey. aydece@dicle.edu.tr

Insights

Children with chronic renal failure (CRF) exhibit increased oxidative stress and reduced antioxidant capacity, indicated by lower paraoxonase (PON) activity and total antioxidant response (TAR). Uremic metabolites and low albumin may contribute to this oxidative stress.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Health
  • Oxidative Stress Research

Background:

  • Oxidative stress is linked to cardiovascular disease risk in uremia.
  • Paraoxonase (PON) activity, an antioxidant enzyme, has not been studied in pediatric chronic renal failure (CRF).

Purpose of the Study:

  • To investigate paraoxonase (PON) activity, total antioxidant response (TAR), total peroxide (TPX), oxidative stress index (OSI), and pro-oxidant cytokines in children with CRF.
  • To compare these markers between children with CRF and healthy controls.

Main Methods:

  • Studied 29 children with CRF (pre-dialysis and CAPD) and 25 controls.
  • Measured PON activity, TAR, TPX, OSI, and selected cytokines.
  • Analyzed correlations between biochemical markers and clinical parameters like serum albumin and urea.

Main Results:

  • Children with CRF showed significantly lower PON and TAR, and higher TPX and OSI compared to controls.
  • The continuous ambulatory peritoneal dialysis (CAPD) subgroup had lower TAR and serum albumin levels.
  • Serum urea positively correlated with TPX and OSI, while TAR correlated with serum albumin.

Conclusions:

  • Children with CRF exhibit increased oxidative stress and diminished antioxidant status.
  • Low serum albumin and high uremic metabolites are potential contributors to oxidative stress in pediatric CRF.
  • Further research with larger cohorts is warranted to validate these findings.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...